Qi Wang from UOB Kay Hian says he is approaching the China markets with a barbell strategy: being defensive by investing in ...

Fact checked by Vikki Velasquez More people need better medicines, and there is a rising demand for food and sustainable solutions. This is why governments and private investors are spending more on ...

In this opinion piece, John Torres, a longtime biotech government affairs executive and policy expert, argues that the farm ...

Opportunities In Biotechnology Will Follow Advancements In The Science. Nov. 25, 2024 2:25 PM ET WDNA. WisdomTree. 5.71K Followers. Follow. Play (14min)Summary. Recent advancements in GLP-1 drugs, ...

A federal commission is calling for $15 billion in new financing to re-enforce the United States’ biotech leadership amid encroaching competition from China.

Congress should invest at least $15 billion to support biotech research over the next five years and take other steps to bolster manufacturing in the U.S., the report said.

We speak with independent regulatory affairs consultant, Mark Richardson, to get an update on the biotech regulatory landscape and to find out what advances we can expect in the next decade or so.

The bipartisan National Security Commission on Emerging Biotechnology (NSCEB), which includes 11 commissioners, was created to examine the issues surrounding U.S. biotechnology advancements and ...

Recent federal actions could derail decades of progress. Meanwhile China has prioritized investment in biotech.

Biotechnology articles from across Nature Portfolio. ... Owing to advances in genome sequencing and editing, a genome can now be redesigned, synthesized and introduced into cells as desired.

Biotech Breakthroughs Fuel Market Growth. Several biotech therapies are showing significant efficacy across various medical conditions, driving both medical advancements and investor enthusiasm.